Connor, Clark & Lunn Investment Management (CC&L)
TSHA icon

Connor, Clark & Lunn Investment Management (CC&L)’s Taysha Gene Therapies TSHA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TSHA Stock Details TSHA Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-112,413
Closed -$323K – 1700
2024
Q1 		$323K Buy
112,413
+77,013
+218% +$221K ﹤0.01% 1243
2023
Q4 		$62.7K Buy
+35,400
New +$62.7K ﹤0.01% 1333